The Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidates for the Treatment of Cancer (Gdc-0152)
Journal Article
·
· J. Med. Chem. 55: 4101-4113,2012
OSTI ID:1091276
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1091276
- Report Number(s):
- SLAC-REPRINT-2013-443
- Journal Information:
- J. Med. Chem. 55: 4101-4113,2012, Journal Name: J. Med. Chem. 55: 4101-4113,2012
- Country of Publication:
- United States
- Language:
- English
Similar Records
The Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins And Clinical Candidates for the Treatment of Cancer (GDC-0152)
The Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidates for the Treatment of Cancer (GDC-0152)
Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer
Journal Article
·
Mon Sep 16 00:00:00 EDT 2013
· J. Med. Chem. 55:4101-4113,2012
·
OSTI ID:1091276
+18 more
The Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidates for the Treatment of Cancer (GDC-0152)
Journal Article
·
Thu Sep 25 00:00:00 EDT 2014
· J. Med. Chem. 55, 4101, 2012
·
OSTI ID:1091276
Discovery of a Novel Class of Exquisitely Selective Mesenchymal-Epithelial Transition Factor (c-MET) Protein Kinase Inhibitors and Identification of the Clinical Candidate 2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol (PF-04217903) for the Treatment of Cancer
Journal Article
·
Wed Feb 27 00:00:00 EST 2013
· J. Med. Chem.
·
OSTI ID:1091276
+20 more